Inomagen Therapeutics reported raising $200,000 in an initial SEC Form D filing, from an offering of $6.63 Million
Round Type
Pre-Seed
ChicagoBiotechnologyWho else raised in Biotechnology around the same time
Companies in the same sectors as Inomagen Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- May Health raised $25M (Series B) on May 13, 2024.
- Lycia Therapeutics, Inc. raised $106M (Series C) on May 13, 2024.
- MedInTech raised $15M (Series B) on May 13, 2024.
- ArgusEye raised $3M (Seed) on May 13, 2024.
- Ajax Therapeutics, Inc. raised $95M (Series C) on May 13, 2024.
- CereVasc raised $70M (Series B) on May 13, 2024.
Who to call at Inomagen Therapeutics, and when
A new round usually means Inomagen Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Inomagen Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Inomagen Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Inomagen Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Inomagen Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Inomagen Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.